PERKINELMER, INC.
$NYSE:PKI
53 watching
PERKINELMER, INC.
$NYSE:PKI
53 watching

PerkinElmer: Capital Budgeting A Key Factor To The Investment Debate

Investment summary

Firms can create value for their investors in many different ways, ranging from capital appreciation of equity, return of capital (dividends, buybacks), and through acquisitions. Each scenario is typically underpinned by the fundamental drivers of...

more

PerkinElmer Announces Quarterly Dividend of $0.07 per Share

Trending News

PerkinElmer, a global leader in life sciences, diagnostics, and analytical technologies, announced its quarterly dividend of $0.07 per share. This payment is in line with the company’s previous quarterly dividend payments and is payable on May 12th to shareholders of record as of...

more

Investing $10K in PerkinElmer Over 5 Years Yields Impressive Results!

Trending News

Investing $10K in PerkinElmer over five years has proven to be a wise decision, yielding impressive results. PerkinElmer is a global leader in the development and production of technology for the life sciences, industrial, and diagnostics markets. PerkinElmer is committed to...

more

PerkinElmer declares $0.07 dividend

  • PerkinElmer (NYSE:PKI) declares $0.07/share quarterly dividend, in line with previous.
  • Payable May 12; for shareholders of record April 21; ex-div April 20.
  • See PKI Dividend Scorecard, Yield Chart, & Dividend Growth.
...

https://seekingalpha.com/news/39286...

$NYSE:PKI

...

more

Danaher earnings weigh on other life sciences tools, services companies

  • Danaher (NYSE:DHR), which reported slowing topline growth in its Q4 2022 financial results earlier Tuesday, is impacting other life sciences tools and services providers.
  • The biggest decliner among peers is Repligen...

more

PerkinElmer, Inc. (PKI) 41st Annual J.P. Morgan Healthcare Conference (Transcript)

PerkinElmer, Inc. (PKI)

41st Annual J.P. Morgan Healthcare Conference Call

January 10, 2023 11:15 AM ET

Company Participants

Prahlad Singh - President and Chief Executive Officer

Conference Call...

more
137.53 0.02%
USD, PERKINELMER, INC.
PerkinElmer provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments: diagnostics, which includes immunodiagnostics, reproductive health, and applied genomics, and discovery and analytical solutions, composed of life science, industrial, environmental, and food applications. PerkinElmer offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
See more

All statements, views or opinions expressed here are the personal views of our users. They do not represent nor should they be construed as representing our statements, views or opinions. For the avoidance of doubt, any such statements, views or opinions are not and shall not be construed as financial advice.

Make Smart Investment Choices